Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

This study has been completed.

Study NCT00076037 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: January 13, 2004 Last Updated: September 23, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given